IN2014CN03130A - - Google Patents
Info
- Publication number
- IN2014CN03130A IN2014CN03130A IN3130CHN2014A IN2014CN03130A IN 2014CN03130 A IN2014CN03130 A IN 2014CN03130A IN 3130CHN2014 A IN3130CHN2014 A IN 3130CHN2014A IN 2014CN03130 A IN2014CN03130 A IN 2014CN03130A
- Authority
- IN
- India
- Prior art keywords
- represent
- npt
- preventive
- formula
- iib
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
- C07D333/80—Seven-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
- C07F9/655354—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011236533 | 2011-10-27 | ||
| PCT/JP2012/077660 WO2013062065A1 (fr) | 2011-10-27 | 2012-10-25 | Dérivé de n-thiényl benzamide substitué avec un aminoalkyle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN03130A true IN2014CN03130A (fr) | 2015-07-03 |
Family
ID=48167891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3130CHN2014 IN2014CN03130A (fr) | 2011-10-27 | 2012-10-25 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9062032B2 (fr) |
| EP (1) | EP2772490B1 (fr) |
| JP (2) | JP2013107880A (fr) |
| KR (1) | KR101941048B1 (fr) |
| CN (1) | CN103906741B (fr) |
| AR (1) | AR088563A1 (fr) |
| AU (1) | AU2012329913A1 (fr) |
| CA (1) | CA2853688C (fr) |
| EA (1) | EA023955B1 (fr) |
| ES (1) | ES2585415T3 (fr) |
| IL (1) | IL232230A0 (fr) |
| IN (1) | IN2014CN03130A (fr) |
| MX (1) | MX342521B (fr) |
| PL (1) | PL2772490T3 (fr) |
| TW (1) | TW201323419A (fr) |
| WO (1) | WO2013062065A1 (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT2903968T (lt) | 2012-10-02 | 2017-02-27 | Gilead Sciences, Inc. | Histondemetilazių inhibitoriai |
| US9499553B2 (en) | 2013-03-13 | 2016-11-22 | Chugai Seiyaku Kabushiki Kaisha | Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same |
| SI2975030T1 (sl) | 2013-03-13 | 2020-10-30 | Chugai Seiyaku Kabushiki Kaisha | Derivat dihidropiridazin-3,5-diona |
| TWI594975B (zh) * | 2013-04-24 | 2017-08-11 | 第一三共股份有限公司 | 二羧酸化合物 |
| CN105658655B (zh) | 2013-08-08 | 2018-11-13 | 加拉佩格斯股份有限公司 | 作为CFTR调节剂的噻吩并[2,3-c]吡喃 |
| WO2015064532A1 (fr) * | 2013-10-30 | 2015-05-07 | 第一三共株式会社 | Composé de morpholine |
| EP3126345A1 (fr) * | 2014-03-31 | 2017-02-08 | Gilead Sciences, Inc. | Inhibiteurs d'histones déméthylases |
| CN105658635B (zh) * | 2014-08-22 | 2019-03-08 | 江苏恒瑞医药股份有限公司 | 噻吩并环烷基或噻吩并杂环基类衍生物、其制备方法及其在医药上的应用 |
| ES2881611T3 (es) | 2014-09-12 | 2021-11-30 | Chugai Pharmaceutical Co Ltd | Producto farmacéutico que contiene inhibidor del transportador de fosfato dependiente de sodio |
| CN107074793B (zh) | 2014-09-26 | 2019-08-23 | 第一三共株式会社 | 二羧酸化合物的盐 |
| CN105524053B (zh) * | 2014-10-19 | 2020-06-05 | 广东东阳光药业有限公司 | 四氢苯并噻吩化合物 |
| TW201700458A (zh) | 2015-04-24 | 2017-01-01 | 第一三共股份有限公司 | 二羧酸化合物之製法 |
| CN107082773B (zh) * | 2016-02-16 | 2020-07-28 | 江苏恒瑞医药股份有限公司 | 一种肠2b型磷酸钠协同转运蛋白抑制剂的硫酸盐及其结晶形式 |
| WO2018034883A1 (fr) * | 2016-08-15 | 2018-02-22 | Eli Lilly And Company | Dérivés de thiophène condensés utiles en tant qu'inhibiteurs de napi-iib |
| JOP20190080A1 (ar) | 2016-10-14 | 2019-04-11 | Bayer Pharma AG | مركبات مشتقة من 6-(1h-بيرازول-1-يل) بيريميدين-4- أمين مستبدل واستخداماتها |
| CN109422723B (zh) * | 2017-08-25 | 2021-02-23 | 江苏恒瑞医药股份有限公司 | 一种肠2b型磷酸钠协同转运蛋白抑制剂的晶型及其制备方法 |
| AR126060A1 (es) | 2021-06-08 | 2023-09-06 | Chugai Pharmaceutical Co Ltd | Método para producir derivado de dihidropiridazin-3,5-diona |
| TW202317118A (zh) | 2021-06-08 | 2023-05-01 | 日商中外製藥股份有限公司 | 含有二氫嗒-3，5-二酮衍生物的製劑 |
| WO2023203254A2 (fr) | 2022-04-22 | 2023-10-26 | Fundamental Pharma Gmbh | Moyens efficaces pour moduler la toxicité médiée par le récepteur nmda |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002213048A1 (en) * | 2000-10-05 | 2002-04-15 | Smith Kline Beecham Corporation | Phosphate transport inhibitors |
| JP2007131532A (ja) | 2001-09-28 | 2007-05-31 | Kirin Brewery Co Ltd | 生体内リン輸送を阻害する化合物およびそれを含んでなる医薬 |
| WO2003048134A1 (fr) * | 2001-12-05 | 2003-06-12 | Japan Tobacco Inc. | Compose de triazole et son utilisation therapeutique |
| WO2004085382A1 (fr) * | 2003-03-27 | 2004-10-07 | Kirin Beer Kabushiki Kaisha | Compose inhibiteur in vivo de transport de phosphore et medicament en contenant |
| WO2006093518A2 (fr) | 2004-06-25 | 2006-09-08 | Apath, Llc | Composes thienyle pour traiter des etats pathologiques lies a un virus |
| CA2579089A1 (fr) | 2004-08-30 | 2006-03-09 | Government Of The United States Of America As Represented By The Secreta Ry Department Of Health And Human Services | Methodes et compositions ayant trait a l'inhibition de virus utilisant des inhibiteurs de rnase h |
| WO2006044826A2 (fr) | 2004-10-20 | 2006-04-27 | Compass Pharmaceuticals Llc | Compositions et leur utilisation en tant qu'agents antitumoraux |
| CN101910126B (zh) * | 2008-01-08 | 2014-04-30 | 普渡制药公司 | 作为***素受体之配体的脯氨酸类似物 |
| US20130029973A1 (en) | 2010-04-28 | 2013-01-31 | Astellas Pharma Inc. | Tetrahydrobenzothiophene compound |
| EP2590655B1 (fr) | 2010-07-07 | 2015-06-24 | Ardelyx, Inc. | Composés et procédés pour l'inhibition du transport de phosphate |
| WO2012006477A1 (fr) | 2010-07-07 | 2012-01-12 | Ardelyx, Inc. | Composés et procédés pour l'inhibition du transport de phosphate |
| EP2591354B1 (fr) | 2010-07-07 | 2016-09-07 | Ardelyx, Inc. | Composés et procédés pour l'inhibition du transport de phosphate |
| WO2012006474A2 (fr) * | 2010-07-07 | 2012-01-12 | Ardelyx, Inc. | Composés et procédés pour l'inhibition du transport de phosphate |
| EP2590656B1 (fr) | 2010-07-07 | 2017-11-15 | Ardelyx, Inc. | Composés et procédés permettant d'inhiber le transport du phosphate |
-
2012
- 2012-10-25 MX MX2014005090A patent/MX342521B/es active IP Right Grant
- 2012-10-25 PL PL12844048.4T patent/PL2772490T3/pl unknown
- 2012-10-25 IN IN3130CHN2014 patent/IN2014CN03130A/en unknown
- 2012-10-25 JP JP2012236135A patent/JP2013107880A/ja active Pending
- 2012-10-25 CA CA2853688A patent/CA2853688C/fr active Active
- 2012-10-25 TW TW101139423A patent/TW201323419A/zh unknown
- 2012-10-25 JP JP2013540835A patent/JP6020460B2/ja active Active
- 2012-10-25 EP EP12844048.4A patent/EP2772490B1/fr active Active
- 2012-10-25 KR KR1020147014256A patent/KR101941048B1/ko active IP Right Grant
- 2012-10-25 ES ES12844048.4T patent/ES2585415T3/es active Active
- 2012-10-25 AU AU2012329913A patent/AU2012329913A1/en not_active Abandoned
- 2012-10-25 CN CN201280053147.6A patent/CN103906741B/zh active Active
- 2012-10-25 EA EA201490875A patent/EA023955B1/ru not_active IP Right Cessation
- 2012-10-25 WO PCT/JP2012/077660 patent/WO2013062065A1/fr active Application Filing
- 2012-10-25 US US14/354,086 patent/US9062032B2/en active Active
- 2012-10-26 AR ARP120104035A patent/AR088563A1/es unknown
-
2014
- 2014-04-24 IL IL232230A patent/IL232230A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201323419A (zh) | 2013-06-16 |
| CA2853688C (fr) | 2018-06-12 |
| US20150031727A1 (en) | 2015-01-29 |
| US9062032B2 (en) | 2015-06-23 |
| AU2012329913A1 (en) | 2014-05-22 |
| WO2013062065A1 (fr) | 2013-05-02 |
| EA023955B1 (ru) | 2016-07-29 |
| EA201490875A1 (ru) | 2014-09-30 |
| JP6020460B2 (ja) | 2016-11-02 |
| EP2772490A4 (fr) | 2015-01-21 |
| EP2772490B1 (fr) | 2016-04-06 |
| KR20140096322A (ko) | 2014-08-05 |
| CA2853688A1 (fr) | 2013-05-02 |
| ES2585415T3 (es) | 2016-10-05 |
| IL232230A0 (en) | 2014-06-30 |
| EP2772490A1 (fr) | 2014-09-03 |
| AR088563A1 (es) | 2014-06-18 |
| MX342521B (es) | 2016-10-03 |
| KR101941048B1 (ko) | 2019-01-22 |
| PL2772490T3 (pl) | 2016-11-30 |
| CN103906741B (zh) | 2016-01-20 |
| JP2013107880A (ja) | 2013-06-06 |
| BR112014010169A2 (pt) | 2017-04-25 |
| JPWO2013062065A1 (ja) | 2015-04-02 |
| CN103906741A (zh) | 2014-07-02 |
| MX2014005090A (es) | 2015-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014CN03130A (fr) | ||
| RS53301B (en) | TIOACETATE COMPOUNDS, COMPOSITIONS AND USE PROCEDURES | |
| IN2015MN00405A (fr) | ||
| TN2011000400A1 (en) | Inhibitors of beta-secretase | |
| BR112014017749A8 (pt) | Composto alquinilbenzeno 3,5-dissubstituído e sal do mesmo | |
| MX356342B (es) | Agente de control de endoparásitos y método para usarlo. | |
| MX348422B (es) | Inhibidores de arginasa y sus aplicaciones terapeuticas. | |
| MX336381B (es) | Boronatos como inhibidores de arginasa. | |
| IN2014CN00712A (fr) | ||
| MX2013001805A (es) | Derivados de 2-(arilamino)-3h-imidazo [4,5-b] piridina-6-carboxamida y su uso como inhibidores de mpges-1. | |
| AU2012214029A8 (en) | Rorgammat inhibitors | |
| TN2014000122A1 (en) | 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases | |
| CL2009000650A1 (es) | Compuestos derivados de amino-pirazina, inhibidores de cinasa-pi 3; composicion farmaceutica; y uso para el tratamiento de condiciones inflamatorias o alérgicas, tales como enfermedades respiratorias, artritis reumatoide, colitis ulcerativa, entre otras | |
| TN2015000245A1 (en) | Heterocyclic compound | |
| GEP20146197B (en) | New compounds | |
| EA201291121A1 (ru) | Соединения тетрагидробензотиофена | |
| MX351812B (es) | Derivados de piridona. | |
| MA35402B1 (fr) | Compositions pesticides et procédés associés | |
| UA108926C2 (ru) | LibreOffice? [2,3-D] +" +" !+ | |
| MY172924A (en) | Neprilysin inhibitors | |
| IN2014CN04204A (fr) | ||
| MY167898A (en) | Co-crystals and salts of ccr3-inhibitors | |
| IN2012DN02502A (fr) | ||
| IN2014CN04449A (fr) | ||
| IN2013CN01335A (fr) |